Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging

被引:175
作者
Rajagopalan, N
Miller, TD
Hodge, DO
Frye, RL
Gibbons, RJ
机构
[1] Mayo Clin, Rochester, MN 55905 USA
[2] Mayo Fdn, Dept Internal Med, Rochester, MN USA
[3] Mayo Fdn, Dept Cardiovasc Dis, Rochester, MN USA
[4] Mayo Fdn, Dept Cardiovasc Dis, Rochester, MN USA
[5] Mayo Fdn, Dept Biostat, Rochester, MN USA
关键词
D O I
10.1016/j.jacc.2004.06.078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this study was to identify which asymptomatic diabetic patients are candidates for screening single-photon emission computed tomography (SPECT) imaging and to examine angiographic findings and mortality in patients according to SPECT imaging categories. BACKGROUND Previously we reported a high percentage of abnormal and high-risk SPECT imaging scans in asymptomatic diabetic patients. METHODS We examined the associations between several clinical and laboratory variables and a high-risk stress SPECT imaging scan in 1,427 asymptomatic diabetic patients without known coronary artery disease (CAD). Results of coronary angiography and long-term outcome were also analyzed. RESULTS An abnormal stress SPECT imaging scan was present in 826 patients (58%) and a high-risk scan in 261 patients (18%). Multivariate analysis demonstrated that seven variables were independently associated with a high-risk scan (model chi-square = 107, p < 0.0001). The two most important variables were electrocardiogram (ECG) Q waves (adjusted chi-square = 38.3, p < 0.001) and peripheral arterial disease (PAD) (adjusted chi-square = 13.9, p < 0.001). Coronary angiography was performed in 127 (49%) high-risk SPECT imaging patients, 61% of whom had angiographic high-risk CAD. Annual mortality rates for patient subsets categorized by SPECT imaging scans were high-risk 5.9%, intermediate-risk 5.0%, and low-risk 3.6% (p < 0.001 for differences between groups). CONCLUSIONS High-risk findings on stress SPECT imaging were present in 18% of asymptomatic diabetic patients without known CAD. Patients with high-risk scans had a high prevalence of severe CAD and a high annual mortality rate. ECG Q waves and/or evidence of PAD identified the most suitable candidates for screening. (C) 2005 by the American College of Cardiology Foundation.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 39 条
[1]   EXERCISE TESTING WITH MYOCARDIAL SCINTIGRAPHY IN ASYMPTOMATIC DIABETIC MALES [J].
ABENAVOLI, T ;
RUBLER, S ;
FISHER, VJ ;
AXELROD, HI ;
ZUCKERMAN, KP .
CIRCULATION, 1981, 63 (01) :54-64
[2]  
*AM DIAB ASS, 1998, DIABETES CARE, V21, P1551
[3]  
[Anonymous], 1997, Am J Cardiol, V79, P134
[4]   Critical issues in peripheral arterial disease detection and management - A call to action [J].
Belch, JJF ;
Topol, EJ ;
Agnelli, G ;
Bertrand, M ;
Califf, RM ;
Clement, DL ;
Creager, MA ;
Easton, JD ;
Gavin, JR ;
Greenland, P ;
Hankey, G ;
Hanrath, P ;
Hirsch, AT ;
Meyer, J ;
Smith, SC ;
Sullivan, F ;
Weber, MA .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (08) :884-892
[5]   Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men - Impact of diabetes mellitus on incremental prognostic value and effect on patient management [J].
Berman, DS ;
Kang, XP ;
Hayes, SW ;
Friedman, JD ;
Cohen, I ;
Abidov, A ;
Shaw, LJ ;
Amanullah, AM ;
Germano, G ;
Hachamovitch, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) :1125-1133
[6]  
Bonow Robert O., 1996, American Journal of Medicine, V101, p17S, DOI 10.1016/S0002-9343(96)00312-9
[7]   Principles from clinical trials relevant to clinical practice: Part I [J].
Califf, RM ;
DeMets, DL .
CIRCULATION, 2002, 106 (08) :1015-1021
[8]  
*CASS, 1981, CIRCULATION, V63, P1
[9]   NONINVASIVE IDENTIFICATION OF SEVERE CORONARY-ARTERY DISEASE USING EXERCISE TOMOGRAPHIC TL-201 IMAGING [J].
CHRISTIAN, TF ;
MILLER, TD ;
BAILEY, KR ;
GIBBONS, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (01) :14-20
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497